MARATTO

article · Nigerian Journal of Oncology

CASE REPORT: A RARE CASE OF BREAST METASTASIS FROM MUCINOUS RECTAL CARCINOMA

2025Open accessGombe State University

In plain language

Colorectal cancer typically metastasises to the liver, lungs, and peritoneum, making spread to the breast exceptionally rare. A case involving a patient naive to chemotherapy and radiotherapy highlights this presentation, where the individual arrived with signs of colorectal cancer alongside a groin mass and a breast mass. Subsequent biopsy and histopathological analysis confirmed primary rectal mucinous carcinoma with metastatic mucinous carcinoma in the breast tissue. Clinical staging revealed peritoneal deposits as well as inguinal and para-aortic lymph node involvement, despite an absence of disease in the liver or lungs. The condition progressed rapidly, and the patient died roughly two months following the initial presentation. Clinical awareness of potential breast metastasis from rectal cancer is vital, as unusual secondary sites can be overlooked. Proper diagnosis relies on careful clinical evaluation, histology, and immunohistochemistry to ensure timely recognition and management.

Key takeaways

  • Breast metastasis originating from colorectal cancer is an exceptionally rare condition associated with a very poor clinical prognosis.
  • A patient presented with rectal mucinous carcinoma alongside metastatic breast involvement, peritoneal deposits, and affected lymph nodes without liver or lung spread.
  • The disease progressed rapidly, resulting in the patient passing away approximately two months after initial presentation.
  • Accurate recognition of rare metastatic sites requires thorough physical examination, histological assessment, and immunohistochemistry.

Why it matters

Recognising atypical patterns of cancer progression helps clinicians identify secondary tumours that might otherwise be misidentified as separate primary cancers. Although colorectal cancer usually spreads to the liver and lungs, unusual sites such as the breast can occur. Accurate diagnosis through tissue examination ensures that patients receive appropriate care and realistic prognostic evaluations during advanced disease management.

Commercialisation angle

The abstract does not indicate an application pathway.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

Introduction: There are few cases of breast metastases from colorectal cancer (CRC). The most common sites of metastases of colorectal cancer are the liver, lungs and the peritoneum. Breast metastases from colorectal cancers are very rare and metastases to distant sites signify a very poor prognosis. We report a case of a chemotherapy and radiotherapy treatment naive patient who presented with clinical features suggestive of colorectal cancer, a groin mass and a breast mass. Biopsy and histopathological assessment of the rectal and breast mass samples showed rectal mucinous carcinoma and metastatic mucinous carcinoma respectively. Staging investigations done showed peritoneal deposits, inguinal and paraaortic lymph nodes involvement, but no metastasis to the lungs and liver. She however passed away approximately two months after presentation. The awareness of the possibility of rectal cancer to metastasize to the breast is important, as this can be missed due to its location. A good history, physical examination, histology and immunohistochemistry are very vital for appropriate diagnosis and by extension treatment of these patients.

Research topics

  • Metastasis and carcinoma case studies
  • Breast Lesions and Carcinomas
  • Ovarian cancer diagnosis and treatment

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.67579/njo.2025.a5ebkloc

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.